Abstract

Preventive zinc supplementation provided as a stand-alone dispersible tablet, or via home fortification as multiple micronutrient powders (MNPs), has been considered a potential strategy to prevent zinc deficiency and improve health (including immune) outcomes among children in low- and middle-income countries. However, the impact of zinc supplementation on immune profiles has not been well characterized. We sought to define the effect of zinc supplementation on peripheral blood gene expression and cytokine levels among young children in Dhaka, Bangladesh. In a sub-study of a large randomized, controlled, community-based efficacy trial where children 9–11 months of age received one of the following interventions on a daily basis for 24 weeks: (1) MNPs containing 10 mg of zinc; (2) dispersible tablet containing 10 mg zinc; or (3) placebo powder, we used RNA sequencing to profile the peripheral blood gene expression, as well as highly sensitive multiplex assays to detect cytokine profiles. We profiled samples from 100 children enrolled in the parent trial (zinc MNPs 28, zinc tablets 39, placebo 33). We did not detect an effect from either zinc intervention on differential peripheral blood gene expression at the end of the intervention, or an effect from the intervention on changes in gene expression from baseline. We also did not detect an effect from either intervention on cytokine concentrations. Exploratory analysis did not identify an association between undernutrition (defined as stunting, underweight or wasting) and peripheral blood gene expression. Zinc interventions in children did not produce a gene expression or cytokine signature in the peripheral blood. However, this study demonstrates a proof of principle that sensitive multi-omic techniques can be applied to samples collected in field studies.

Highlights

  • Over 17% of the world’s population has been considered at risk of inadequate nutritional zinc intake [1], and zinc deficiency is especially widespread across low- and middle-income countries [2]

  • These included a total of 100 endline and 96 matched baseline whole blood samples, and 100 endline and 99 matched baseline serum samples from the zinc micronutrient powders (MNPs), zinc tablet and placebo groups (Figure 1)

  • We did not detect an effect from either supplemental zinc tablets or MNPs containing high-dose zinc on peripheral blood gene expression or cytokine levels, nor could we detect a clear association between peripheral blood gene expression profiles and child growth

Read more

Summary

Introduction

Over 17% of the world’s population has been considered at risk of inadequate nutritional zinc intake [1], and zinc deficiency is especially widespread across low- and middle-income countries [2]. Therapeutic zinc supplementation reduces the duration of diarrhea in children [3] and is part of the World Health Organization (WHO) Integrated. Preventive zinc supplementation provided as a stand-alone dispersible tablet, or via home fortification as multiple micronutrient powders (MNPs), has been considered a potential strategy to prevent zinc deficiency in low- and middle-income countries (LMICs). Such an approach could improve functional outcomes including reduced diarrhea, improved child growth and lower mortality [5,6]. The impact of preventive zinc supplementation in children on immune function has not been clearly defined experimentally

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call